Published in Transplantation on May 15, 2006
Health-related quality of life in kidney donors from the last five decades: results from the RELIVE study. Am J Transplant (2013) 1.34
Prevention of poor psychosocial outcomes in living organ donors: from description to theory-driven intervention development and initial feasibility testing. Prog Transplant (2012) 0.96
Emotional and Financial Experiences of Kidney Donors over the Past 50 Years: The RELIVE Study. Clin J Am Soc Nephrol (2015) 0.81
Interaction of physical function, quality of life and depression in Amyotrophic lateral sclerosis: characterization of a large patient cohort. BMC Neurol (2015) 0.80
Decision making around living and deceased donor kidney transplantation: a qualitative study exploring the importance of expected relationship changes. BMC Nephrol (2012) 0.80
Social and Financial Outcomes of Living Liver Donation: A Prospective Investigation Within the Adult-to-Adult Living Donor Liver Transplantation Cohort Study 2 (A2ALL-2). Am J Transplant (2016) 0.76
Kidney donation--all gifts have a price. Transplantation (2006) 0.75
Quality of life following laparoscopic living-donor nephrectomy. JSLS (2013) 0.75
Living kidney donors and their family caregivers: developing an evidence-based educational and social support website. Prog Transplant (2012) 0.75
Early detection of acute renal failure by serum cystatin C. Kidney Int (2004) 4.62
Albumin dialysis in cirrhosis with superimposed acute liver injury: a prospective, controlled study. Hepatology (2002) 3.16
Augmentation index is associated with cardiovascular risk. J Hypertens (2002) 3.13
Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial. Lancet (2011) 2.82
Eculizumab for atypical hemolytic-uremic syndrome. N Engl J Med (2009) 2.80
Posterior retroperitoneoscopic adrenalectomy--results of 560 procedures in 520 patients. Surgery (2006) 2.35
Prognostic value of tubular proteinuria and enzymuria in nonoliguric acute tubular necrosis. Clin Chem (2004) 2.10
Evidenced-based treatment of opioid-dependent patients. Can J Psychiatry (2006) 1.91
Novel baroreflex activation therapy in resistant hypertension: results of a European multi-center feasibility study. J Am Coll Cardiol (2010) 1.82
Avosentan reduces albumin excretion in diabetics with macroalbuminuria. J Am Soc Nephrol (2009) 1.82
Long-term antihypertensive efficacy and safety of the oral direct renin inhibitor aliskiren: a 12-month randomized, double-blind comparator trial with hydrochlorothiazide. Circulation (2009) 1.82
Acute myocardial infarction in thrombotic microangiopathies--clinical characteristics, risk factors and outcome. Nephrol Dial Transplant (2006) 1.76
Effects of renal impairment on the pharmacokinetics, pharmacodynamics and safety of rivaroxaban, an oral, direct Factor Xa inhibitor. Br J Clin Pharmacol (2010) 1.71
Physical and mental health in severe opioid-dependent patients within a randomized controlled maintenance treatment trial. Addiction (2011) 1.59
Clonidine lowers blood pressure by reducing vascular resistance and cardiac output in young, healthy males. Cardiovasc Drugs Ther (2005) 1.55
Heroin-assisted treatment (HAT) a decade later: a brief update on science and politics. J Urban Health (2007) 1.40
A cell-based approach to the minimization of immunosuppression in renal transplantation. Transpl Int (2008) 1.24
Executive functioning in obsessive-compulsive disorder, unipolar depression, and schizophrenia. Arch Clin Neuropsychol (2002) 1.14
Amlodipine and valsartan combined and as monotherapy in stage 2, elderly, and black hypertensive patients: subgroup analyses of 2 randomized, placebo-controlled studies. J Clin Hypertens (Greenwich) (2007) 1.12
Partial versus total adrenalectomy by the posterior retroperitoneoscopic approach: early and long-term results of 325 consecutive procedures in primary adrenal neoplasias. World J Surg (2004) 1.12
Diagnostic value of various biochemical parameters for the diagnosis of pheochromocytoma in patients with adrenal mass. Eur J Endocrinol (2006) 1.09
Endoscopic treatment of solitary, bilateral, multiple, and recurrent pheochromocytomas and paragangliomas. World J Surg (2002) 1.08
Long-term efficacy of the complement inhibitor eculizumab in cold agglutinin disease. Blood (2009) 1.08
Benzodiazepine use among patients in heroin-assisted vs. methadone maintenance treatment: findings of the German randomized controlled trial. Drug Alcohol Depend (2010) 1.08
Long-term effects of heroin-assisted treatment in Germany. Addiction (2008) 1.07
Multiple viral hepatitis in injection drug users and associated risk factors. J Gastroenterol Hepatol (2007) 1.04
Cocaine use in Europe - a multi-centre study: patterns of use in different groups. Eur Addict Res (2004) 1.03
The Arg389Gly beta1-adrenoceptor polymorphism and catecholamine effects on plasma-renin activity. J Am Coll Cardiol (2005) 1.02
G-protein-coupled receptor kinase activity in human heart failure: effects of beta-adrenoceptor blockade. Cardiovasc Res (2005) 0.99
Migration and schizophrenia: the challenges for European psychiatry and implications for the future. Soc Psychiatry Psychiatr Epidemiol (2004) 0.96
Treatment of alcohol hallucinosis with risperidone. Am J Addict (2007) 0.96
Guidelines for the treatment of hepatitis C virus infection in injection drug users: status quo in the European Union countries. Clin Infect Dis (2005) 0.96
Dissociative symptoms in alcohol-dependent patients: associations with childhood trauma and substance abuse characteristics. Compr Psychiatry (2007) 0.95
Significance of comorbidity for the long-term course of opiate dependence. Eur Addict Res (2005) 0.94
Effect of zotepine, olanzapine and risperidone on hostility in schizophrenic patients. Schizophr Res (2002) 0.91
Successful treatment of chronic hepatitis C virus infection in severely opioid-dependent patients under heroin maintenance. Drug Alcohol Depend (2010) 0.90
New psychiatric and psychological aspects of diagnosis and treatment of hepatitis C and relevance for opiate dependence. Curr Opin Psychiatry (2005) 0.90
Aspects of quality of life through end-stage renal disease. Qual Life Res (2003) 0.90
Coronary artery bypass surgery and acute kidney injury--impact of the off-pump technique. Nephrol Dial Transplant (2008) 0.90
Human beta2-adrenergic receptor gene haplotypes and venodilation in vivo. Clin Pharmacol Ther (2005) 0.90
Impact of childhood trauma on hypothalamus-pituitary-adrenal axis activity in alcohol-dependent patients. Eur Addict Res (2010) 0.90
Laser Doppler imager (LDI) scanner and intradermal injection for in vivo pharmacology in human skin microcirculation: responses to acetylcholine, endothelin-1 and their repeatability. Br J Clin Pharmacol (2005) 0.89
Left ventricular ejection time: a potential determinant of pulse wave velocity in young, healthy males. J Hypertens (2003) 0.89
[Quality of life in patients before and after kidney transplantation]. Psychother Psychosom Med Psychol (2002) 0.89
Alexithymia and outcome in psychotherapy. Psychother Psychosom (2008) 0.87
Genotype-dependent time course of lymphocyte beta 2-adrenergic receptor down-regulation. Clin Pharmacol Ther (2003) 0.87
Differential tissue distribution of the Invs gene product inversin. Cell Tissue Res (2005) 0.87
Enhanced vasoconstriction to endothelin-1, angiotensin II and noradrenaline in carriers of the GNB3 825T allele in the skin microcirculation. Pharmacogenetics (2002) 0.87
Which patients benefit from hemodialysis therapy in hepatorenal syndrome? J Gastroenterol Hepatol (2004) 0.86
Unchanged G-protein-coupled receptor kinase activity in the aging human heart. J Am Coll Cardiol (2003) 0.86
The Invs gene encodes a microtubule-associated protein. J Am Soc Nephrol (2004) 0.85
ELISpot assay as a sensitive tool to detect cellular immunity following influenza vaccination in kidney transplant recipients. Clin Immunol (2006) 0.85
Aliskiren-based therapy lowers blood pressure more effectively than hydrochlorothiazide-based therapy in obese patients with hypertension: sub-analysis of a 52-week, randomized, double-blind trial. J Hypertens (2009) 0.84
Quality of life in patients with malignant choroidal melanoma after radiotherapy. Graefes Arch Clin Exp Ophthalmol (2003) 0.84
Quality of life in kidney recipients: comparison of tacrolimus and cyclosporine-microemulsion. Clin Transplant (2002) 0.83
Implication of gender differences in heroin-assisted treatment: results from the German randomized controlled trial. Am J Addict (2010) 0.82
Tacrolimus-based, steroid-free regimens in renal transplantation: 3-year follow-up of the ATLAS trial. Transplantation (2012) 0.82
Central-nervous side effects of midazolam during transesophageal echocardiography. J Am Soc Echocardiogr (2002) 0.82
Noninvasive assessment of microvascular function in arterial hypertension by transthoracic Doppler harmonic echocardiography. J Am Coll Cardiol (2002) 0.82
Effects of systemic endothelin A receptor antagonism in various vascular beds in men: in vivo interactions of the major blood pressure-regulating systems and associations with the GNB3 C825T polymorphism. Clin Pharmacol Ther (2004) 0.81
Efficacy and safety of levetiracetam for the prevention of alcohol relapse in recently detoxified alcohol-dependent patients: a randomized trial. J Clin Psychopharmacol (2012) 0.81
Manifestation of multiple sclerosis with paranoid-hallucinatory psychosis. J Neurol (2006) 0.81
Ezetimibe treatment in hypercholesterolemic kidney transplant patients is safe and effective and reduces the decline of renal allograft function: a pilot study. Nephrol Dial Transplant (2007) 0.80
A patient without monocytes who had pulmonary renal syndrome. Am J Kidney Dis (2004) 0.80
The angiotensin II receptor antagonist valsartan inhibits endothelin 1-induced vasoconstriction in the skin microcirculation in humans in vivo: influence of the G-protein beta3 subunit (GNB3) C825T polymorphism. Clin Pharmacol Ther (2006) 0.80
Belief systems as coping factors for traumatized refugees: a pilot study. Eur Psychiatry (2002) 0.80
[Arterial compliance (stiffness) as a marker of subclinical atherosclerosis]. Herz (2007) 0.80
Serum C3 complement concentrations correlate with liver function in patients with liver cirrhosis. Hepatogastroenterology (2004) 0.80
ATP protects, by way of receptor-mediated mechanisms, against hypoxia-induced injury in renal proximal tubules. J Lab Clin Med (2003) 0.80
T-cell function after interleukin-2 therapy in HIV-infected patients is correlated with serum cortisol concentrations. AIDS (2004) 0.80
Thr164Ile polymorphism of the human beta2-adrenoceptor exhibits blunted desensitization of cardiac functional responses in vivo. Am J Physiol Heart Circ Physiol (2003) 0.79
Comparison of active renin concentration and plasma renin activity for the diagnosis of primary hyperaldosteronism in patients with an adrenal mass. Eur J Endocrinol (2004) 0.79
Bone disease after renal transplantation. Nephrol Dial Transplant (2007) 0.79
In patients chronically treated with metoprolol, the demand of inotropic catecholamine support after coronary artery bypass grafting is determined by the Arg389Gly-beta 1-adrenoceptor polymorphism. Naunyn Schmiedebergs Arch Pharmacol (2007) 0.79
Effect of the C825T polymorphism of the G protein beta 3 subunit on the systolic blood pressure-lowering effect of clonidine in young, healthy male subjects. Clin Pharmacol Ther (2003) 0.79
Insulin-mediated venodilation is impaired in young, healthy carriers of the 825T allele of the G-protein beta3 subunit gene (GNB3). Clin Pharmacol Ther (2005) 0.78
Is there a role of the Thr164Ile-beta(2)-adrenoceptor polymorphism for the outcome of chronic heart failure? Basic Res Cardiol (2006) 0.78
The influence of olanzapine versus risperidone on facial expression of emotions in schizophrenia--preliminary results of a facial electromyogram study. J Clin Psychopharmacol (2005) 0.78
Digital fluorescence imaging of organic cation transport in freshly isolated rat proximal tubules. Drug Metab Dispos (2005) 0.78
Preoperative treatment of a presensitized kidney transplant recipient with donor-derived transplant acceptance-inducing cells. Transpl Int (2008) 0.78
ARTA: AT1-receptor blocker therapy in patients undergoing coronary artery bypass grafting. Clin Res Cardiol (2008) 0.78
Need-adapted HCV-treatment setting for injection drug users. Lancet (2009) 0.78
Prolonged catheter survival in intermittent hemodialysis using a less thrombogenic micropatterned polymer modification. ASAIO J (2003) 0.78
Treatment of drug addiction in traumatised refugees. A case report. Eur Addict Res (2003) 0.78
Interleukin-2 given to asymptomatic HIV-infected individuals leads to an exaggerated response of the pituitary gland to the action of CRH. Clin Endocrinol (Oxf) (2003) 0.77
Association of elevated pretransplant sCD30 levels with graft loss in 206 patients treated with modern immunosuppressive therapies after renal transplantation. Transplantation (2007) 0.77
[Women and hypertension]. Herz (2005) 0.77
Primary failure of arteriovenous fistulae in auto-immune disease. Kidney Blood Press Res (2003) 0.77
Rosiglitazone is a safe and effective treatment option of new-onset diabetes mellitus after renal transplantation. Transpl Int (2005) 0.77
Effect of quercetin on hypoxic injury in freshly isolated rat proximal tubules. J Lab Clin Med (2003) 0.77
Free androgen index is superior to total testosterone for short-term assessment of the gonadal axis after renal transplantation. Horm Res (2005) 0.77
The I1-imidazoline agonist moxonidine decreases sympathetic tone under physical and mental stress. Br J Clin Pharmacol (2004) 0.77
Endothelin-B-receptor-selective antagonist inhibits endothelin-1 induced potentiation on the vasoconstriction to noradrenaline and angiotensin II. J Hypertens (2004) 0.77
Venous response to nitroglycerin is enhanced in young, healthy carriers of the 825T allele of the G protein beta3 subunit gene (GNB3). Clin Pharmacol Ther (2003) 0.77
Switching from methadone to diamorphine: 2-year results of the german heroin-assisted treatment trial. Subst Use Misuse (2011) 0.77